Replies to post #86598 on Value Microcaps Motherboard

[riskanalyst]

Acquisitions would be great if it's another Vancocin, but how likely is that? Preserve the cash and use it to fund development. Their CMV drug in Phase III sounds quite promising. HCV-796 was a downer given the trials were stopped. Though at least the elevated enzyme levels from the two patients did eventually return back to normal. Their pipeline I believe is promising, though not very deep. Which makes this somewhat of a lottery ticket if it wasn't for Vancocin.